TCF7L2 and type 2 diabetes mellitus: The study of Corella et al. [123] documented the role of TMD enriched with EVOO in the risk of developing diabetes mellitus type 2, atherosclerosis, and cardiovascular pathologies in subjects carrying the polymorphism TCF7L2 -rs7903146 (C > T).